AM for SpaceBioprintingMedical AMMoney & Funding

Redwire Space awarded €14 million to develop 3D-BioSystem Facility

The 'one-stop shop' for tissue engineering and regenerative medicine is funded by the Exploration Programme of the European Space Agency

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

Redwire Space NV, a subsidiary of Redwire Corporation, a leader in space infrastructure for the next-generation space economy, has been awarded a €14 million contract funded by the Exploration Programme of the European Space Agency to design, develop, and qualify the 3D-BioSystem Facility.

Being developed by Redwire Space NV, a Belgian legal entity, the 3D-BioSystem Facility will leverage the latest 3D bioprinting technologies to provide a modular, powerful, and unique system to sustain a large number of experiments. Expanding Redwire’s legacy of in-space manufacturing and bioprinting on the International Space Station (ISS) for exploration and improving life on Earth, the 3D-BioSystem Facility will be a ‘one-stop shop’ for tissue engineering and regenerative medicine.

“We are proud to be developing the 3D-BioSystem to advance critical microgravity bioprinting capabilities,” said Erik Masure, Managing Director of Redwire Space NV. “The ability to bioprint cell constructs will be critical for long-duration spaceflight expeditions to the Moon, Mars, and beyond and for sustainable planetary settlements.”

The system will include a 3D bioprinter, 3D cell culture units, and an incubator. The 3D-BioSystem will be able to produce samples in orbit, which can then be further processed there or be returned to ground.

Redwire Space NV’s 3D-BioSystem Facility could be an important tool for better understanding cell-to-cell interactions in thick tissue, creating organoids for drug efficacy and toxicity testing, laying the groundwork for printing vascularized tissue, and, in the future, printing transplantable organ patches for tissue therapy. The system will also help ensure European technological non-dependence and competitiveness.

Redwire’s BioFabrication Facility (BFF), a flight-dedicated 3D bioprinter, is currently operating on the ISS. BFF is being used for the BFF-Meniscus-2 investigation, which will use BFF to print human knee meniscus. The investigation, a collaboration between Redwire and the Uniformed Services University of the Health Sciences Center for Biotechnology, is exploring how space bioprinting could help treat meniscal injuries, one of the most common orthopedic injuries affecting US military service members.

Redwire’s large and diverse catalog of equipment and services is being used by government, institutional, and industrial customers for conducting research in microgravity. Redwire’s on-orbit capabilities are advancing biomedical capabilities, advanced materials manufacturing, and plant biology – all in an effort to accelerate more scientific discovery and deliver more beneficial products on Earth.

Research
Consumer Products AM 2024

This new market study from VoxelMatters provides an in-depth analysis and forecast of polymer and metal AM in the consumer products industry across the three core segments of the additive manufactu...

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close Popup
Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

Technical Cookies
In order to use this website we use the following technically required cookies
  • PHPSESSID
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Save
Accept all Services

Newsletter

Join our 12,000+ Professional community and get weekly AM industry insights straight to your inbox. Our editor-curated newsletter equips executives, engineers, and end-users with crucial updates, helping you stay ahead.